These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38021880)

  • 21. Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
    Ramanathan K; Abel JG; Park JE; Fung A; Mathew V; Taylor CM; Mancini GBJ; Gao M; Ding L; Verma S; Humphries KH; Farkouh ME
    J Am Coll Cardiol; 2017 Dec; 70(24):2995-3006. PubMed ID: 29241487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Culprit-Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial-Extracorporeal Membrane Oxygenation.
    Choi KH; Yang JH; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Ahn CM; Yu CW; Park IH; Jang WJ; Kim HJ; Bae JW; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD; Kang TS; Gwon HC
    J Am Heart Assoc; 2023 May; 12(10):e029792. PubMed ID: 37158104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-year outcomes of multivessel revascularization in very elderly acute coronary syndrome patients.
    Sheridan BC; Stearns SC; Rossi JS; D'Arcy LP; Federspiel JJ; Carey TS
    Ann Thorac Surg; 2010 Jun; 89(6):1889-94; discussion 1894-5. PubMed ID: 20494044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fractional flow reserve to guide and to assess coronary artery bypass grafting.
    Pellicano M; De Bruyne B; Toth GG; Casselman F; Wijns W; Barbato E
    Eur Heart J; 2017 Jul; 38(25):1959-1968. PubMed ID: 28025191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.
    Denormandie P; Simon T; Cayla G; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; le Breton H; Valy Y; Schiele F; Cuisset T; Vanzetto G; Levesque S; Goube P; Nallet O; Angoulvant D; Roubille F; Charles Nelson A; Chatellier G; Danchin N; Puymirat E
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e011314. PubMed ID: 34420366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival in triple-vessel disease: Hybrid coronary revascularization compared to contemporary revascularization methods.
    Basman C; Hemli JM; Kim MC; Seetharam K; Brinster DR; Pirelli L; Kliger CA; Scheinerman SJ; Singh VP; Patel NC
    J Card Surg; 2020 Oct; 35(10):2710-2718. PubMed ID: 32725629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    Fearon WF; Zimmermann FM; De Bruyne B; Piroth Z; van Straten AHM; Szekely L; Davidavičius G; Kalinauskas G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Aminian A; Oldroyd KG; Al-Attar N; Jagic N; Dambrink JE; Kala P; Angerås O; MacCarthy P; Wendler O; Casselman F; Witt N; Mavromatis K; Miner SES; Sarma J; Engstrøm T; Christiansen EH; Tonino PAL; Reardon MJ; Lu D; Ding VY; Kobayashi Y; Hlatky MA; Mahaffey KW; Desai M; Woo YJ; Yeung AC; Pijls NHJ;
    N Engl J Med; 2022 Jan; 386(2):128-137. PubMed ID: 34735046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Percutaneous coronary intervention versus bypass surgery in patients with diabetes and multivessel coronary disease. Coronary revascularization after FREEDOM].
    Dörr R; Stumpf J; Dalibor J; Simonis G; Spitzer SG
    Herz; 2014 May; 39(3):331-42. PubMed ID: 24740094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
    Zimmermann FM; Ding VY; Pijls NHJ; Piroth Z; van Straten AHM; Szekely L; Davidavicius G; Kalinauskas G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Aminian A; Oldroyd KG; Al-Attar N; Jagic N; Dambrink JE; Kala P; Angeras O; MacCarthy P; Wendler O; Casselman F; Witt N; Mavromatis K; Miner SES; Sarma J; Engstrøm T; Christiansen EH; Tonino PAL; Reardon MJ; Otsuki H; Kobayashi Y; Hlatky MA; Mahaffey KW; Desai M; Woo YJ; Yeung AC; De Bruyne B; Fearon WF;
    Circulation; 2023 Sep; 148(12):950-958. PubMed ID: 37602376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of Measuring Fractional Flow Reserve After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease: Insights From the FAME 3 Trial.
    Piroth Z; Otsuki H; Zimmermann FM; Ferenci T; Keulards DCJ; Yeung AC; Pijls NHJ; De Bruyne B; Fearon WF
    Circ Cardiovasc Interv; 2022 Nov; 15(11):884-891. PubMed ID: 36121706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement.
    Botman KJ; Pijls NH; Bech JW; Aarnoudse W; Peels K; van Straten B; Penn O; Michels HR; Bonnier H; Koolen JJ
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):184-91. PubMed ID: 15390344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes: A Pooled Analysis of 4 Randomized Clinical Trials.
    Gaba P; Christiansen EH; Nielsen PH; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Stone GW; Sabik JF; Sabatine MS; Holm NR; Bergmark BA
    JAMA Cardiol; 2023 Jul; 8(7):631-639. PubMed ID: 37256598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasound-guided.
    Nam CW; Yoon HJ; Cho YK; Park HS; Kim H; Hur SH; Kim YN; Chung IS; Koo BK; Tahk SJ; Fearon WF; Kim KB
    JACC Cardiovasc Interv; 2010 Aug; 3(8):812-7. PubMed ID: 20723852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors and Outcomes of Staged Versus One-Time Multivessel Revascularization in Multivessel Coronary Artery Disease: Insights From the VA CART Program.
    Hu PT; Jones WS; Glorioso TJ; Barón AE; Grunwald GK; Waldo SW; Maddox TM; Vidovich M; Banerjee S; Rao SV
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2265-2273. PubMed ID: 30466824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.
    Garcia S; Sandoval Y; Roukoz H; Adabag S; Canoniero M; Yannopoulos D; Brilakis ES
    J Am Coll Cardiol; 2013 Oct; 62(16):1421-31. PubMed ID: 23747787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
    Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
    JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-evaluating the Role of CABG in Acute Coronary Syndromes.
    Farmer D; Jimenez E
    Curr Cardiol Rep; 2020 Sep; 22(11):148. PubMed ID: 32944807
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.